Pulmonary Embolism Secondary to Intravenous Immunoglobulin in a Child with Leukemia

References (8)

1. Ammann EM, Jones MP, Link BK, Carnahan RM, Winiecki SK, Torner JC, McDowell BD, Fireman BH, Chrischilles EA. Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy. Blood 2016;127:200-207
2. Kocak U, Gursel T, Kaya Z, Aral YZ, Albayrak M, Keskin EY, Belen B, Isık M, Oner N. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center. Pediatr Hematol Oncol 2012;29:130-140
3. Degliuomini M, Cooley V, Mauer E, Gerber LM, Acharya S, Kucine N. Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients. J Thromb Thrombolysis 2021;52:209-213
4. Lee YJ, Shin JU, Lee J, Kim K, Kim WS, Ahn JS, Jung CW, Kang WK. A case of deep vein thrombosis and pulmonary thromboembolism after intravenous immunoglobulin therapy. J Korean Med Sci 2007;22:758-761
5. Bilal J, Riaz IB, Hill JL, Zangeneh TT. Intravenous immunoglobulin-induced pulmonary embolism: it is time to act! Am J Ther 2016;23:1074-1077
6. Basta M. Intravenous immunoglobulin-related thromboembolic events - an accusation that proves the opposite. Clin Exp Immunol 2014;178:153-155
7. Flannery MT, Humphrey D. Deep venous thrombosis with pulmonary embolism related to IVIG treatment: a case report and literature review. Case Rep Med 2015;2015:971321
8. Paran D, Herishanu Y, Elkayam O, Shopin L, Ben-Ami R. Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis 2005;16:313-318.